newsfilter
← Latest News
ACCESS Newswire·

Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs

  • Jaguar Health, Inc. initiated the commercial launch of Neonorm Dog on August 26, 2026, extending its Neonorm franchise to companion animals.
  • Neonorm Dog is a plant-based, non-prescription product designed to support normal stool consistency & GI fluid balance in dogs.
  • The product utilizes a standardized botanical extract derived from the sustainably harvested Croton lechleri tree.
  • Neonorm Dog will be available through select online & animal health retail channels, specifically including Amazon & Chewy.
  • The launch aims to broaden Jaguar's commercial footprint in the companion animal market & provide a science-backed alternative to uncertain home remedies.
  • Existing Neonorm products include Neonorm Foal & Neonorm Calf, which support hydration & bowel health in pre-weaned animals.
  • Neonorm Dog is not intended to diagnose, treat, cure, or prevent any disease, nor is it a substitute for veterinary care.
  • Jaguar Health focuses on developing novel proprietary prescription medicines & non-prescription products sustainably derived from rainforest plants.